Boost For Japanese Pharma Market as UBM Announces Rescheduled Japan Pharma and Bio Events

By Ubm Live, PRNE
Sunday, April 24, 2011

Events Now to be Held in Pharma Heartland of Osaka in July; Aims to Reinvigorate Supply Chain Through Continuing to Offer Industry Leading Networking Platform

AMSTERDAM, April 25, 2011 - Leading events organiser UBM Live ( is today happy
to announce that, following the postponement of its CPhI, ICSE, P-MEC and
BioPh Japan events in Tokyo as a result of the recent earthquake in northern
Japan, the events have now been rescheduled and will be held from 13-15 July
at the Intex Osaka Exhibition Centre. The Japanese business community is
intent on picking itself up as quickly as possible from the effects of the
disaster and there is a strong feeling of the need to get back to business as
usual. UBM anticipates that the Osaka events will attract over 150 exhibitors
and around 8,000 visitors.

In addition to being Japan's second largest city, Osaka is the center of
the Kansai area, one of the main regions in Japan for pharmaceutical R&D and
manufacturing, with numerous Japanese and multinational pharmaceutical
companies having their head office, factories and R&D centers located there,
and in surrounding cities. The events are conveniently located for visitors
from prefectures in the Kansai region such as Osaka, Hyogo, Kyoto, Tokushima
and Shiga, as well as other key pharmaceutical manufacturing prefectures with
easy access to Osaka such as Toyama, Shizuoka, Aichi, Gifu and Yamaguchi.

"Following our initial announcement regarding the unfortunate
postponement of the events in Tokyo, we received many requests from
exhibitors asking if there was some way that we could facilitate an
opportunity for them to meet their clients in Japan this year," commented
Annemieke Timmers, CPhI Brand Director. "We also received unanimous feedback
from our Japanese customers and we recognize that it is precisely at times
such as this that CPhI Japan, along with ICSE, P-MEC and BioPh Japan, could
help contribute towards the stable supply of pharmaceutical products in what
is the second largest pharma market after the United States."

"After careful consideration, we decided that it was important to
reschedule the events in 2011 in order to provide the Japanese market with a
recognized, industry-leading platform for networking and learning by bringing
together representatives of the international Pharma community in one
location, allowing them to do business, meet with existing clients and new
prospects, as well as stay informed of developments in the industry," added
Haf Cennydd, Brand Director ICSE, P-MEC and BioPh. "We are currently putting
together a schedule of conference sessions which will run alongside the
events over the three-day period. These will cover a wide variety of topics
relevant to each of the co-located shows that will enhance the educational
experience for exhibitors and visitors alike."

Further information on CPhI, ICSE, P-MEC and BioPh Japan can be found at

UBM Live's annual schedule of global pharma events also includes South
(August 24-26, 2011, Transamerica Expo Center, Sao Paulo, Brazil),
Worldwide (October 25-27, Messe Frankfurt, Germany) and India (November 30-
December 2, 2011
, Bombay Exhibition Centre, Mumbai, India). The Japan events
will return to Tokyo in 2012 and will run from 21-23 March at Tokyo Big
Sight. Further information about CPhI, ICSE, P-MEC and BioPh can be found
online at,,

Notes for Editors:

    - With offices in the UK, Netherlands, USA, UAE and Brazil, UBM Live
      operates a number of market leading exhibitions, awards,
      websites/online products and publications in twenty different business
      sectors. UBM Live is part of UBM Ltd, a leading global media company
      listed on the London Stock Exchange. See

    - UBM Ltd is a leading global business media company. We inform markets
      and bring the world's buyers and sellers together at events, online, in
      print and provide them with the information they need to do business
      successfully. Our 6,000 staff in more than 30 countries are organised
      into specialist teams that serve these communities, helping them to do
      business and their markets to work effectively and efficiently. See

Media Enquiries: Impress Labs, Global (excl. North America): Richard Kerns, richard at, +44-161-728-5880, or North America: Beth Willers, beth at, +1-503-928-7828; or Company Enquiries: UBM Live, Rob Sahi (CPhI), +31-20-40-99-5561, or Ian O'Malley (ICSE, P-MEC, BioPh, LABWorld), +31-20-40-99-5526

Health News

Ubm Live News

will not be displayed